Tilray | TRLY - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Acasti Pharma USD 64.89M 2.07M 2025-12
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.01M 175K 2026-03
Aurora Cannabis CAD 48.04M 81.94M 2026-03
Avita Medical AUD 28.02M 1.55M 2025-12
Canopy Growth CAD 98.72M 11.51M 2026-03
Cronos Group USD 45.4M 1.26M 2026-06
Dianthus Therapeutics USD 47M 22.83M 2026-03
Divis Laboratories Ltd INR 19.51B 660M 2026-06
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
IQVIA Holdings USD 1.77B 4.45B 2026-06
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Moderna USD 960M 817M 2026-06
Organigram Holdings CAD 69.59M 14.08M 2026-03
Organon & Co USD 1.01B 103M 2026-06
Revvity USD 603.55M 24.8M 2026-06
Tectonic Therapeutic USD 27.3M 5.78M 2026-03
Tilray USD 237.52M 17.34M 2025-09
Viatris USD 3.68B 145.9M 2026-06
Xeris Pharmaceuticals USD 75.21M 6.18M 2026-03
Zealand Pharma A/S 573M 202.97M 2026-03